Cardiovascular and oral disease interactions: what is the evidence?
This paper reviews the evidence for the interaction of oral disease (more specifically, periodontal infections) with cardiovascular disease. Cardiovascular disease is a major cause of death worldwide, with atherosclerosis as the underlying aetiology in the vast majority of cases. The importance of the role of infection and inflammation in atherosclerosis is now widely accepted, and there has been increasing awareness that immune responses are central to atherogenesis. Chronic inflammatory periodontal diseases are among the most common chronic infections, and a number of studies have shown an association between periodontal disease and an increased risk of stroke and coronary heart disease. Although it is recognised that large-scale intervention studies are required, pathogenic mechanism studies are nevertheless required so as to establish the biological rationale. In this context, a number of hypotheses have been put forward; these include common susceptibility, inflammation via increased circulating cytokines and inflammatory mediators, direct infection of the blood vessels, and the possibility of cross-reactivity or molecular mimicry between bacterial and self-antigens. In this latter hypothesis, the progression of atherosclerosis can be explained in terms of the immune response to bacterial heat shock proteins (HSPs). Because the immune system may not be able to differentiate between self-HSP and bacterial HSP, an immune response generated by the host directed at pathogenic HSP may result in an autoimmune response to similar sequences in the host. Furthermore, endothelial cells express HSPs in atherosclerosis, and cross-reactive T cells exist in the arteries and peripheral blood of patients with atherosclerosis. Each of these hypotheses is reviewed in light of current research. It is concluded that although atherosclerotic cardiovascular disease is almost certainly a multifactorial disease, there is now strong evidence that infection and inflammation are important risk factors. As the oral cavity is one potential source of infection, it is wise to try to ensure that any oral disease is minimised. This may be of significant benefit to cardiovascular health and enables members of the oral health team to contribute to their patients' general health.
Ford
Pauline J
PJ
Oral Biology and Pathology, School of Dentistry, University of Queensland, Brisbane, Australia. p.ford@uq.edu.au
Yamazaki
Kazuhisa
K
Seymour
Gregory J
GJ
D050197:Atherosclerosis / Q000150:complications / Q000276:immunology; D015551:Autoimmunity / Q000276:immunology; D002318:Cardiovascular Diseases / Q000150:complications* / Q000276:immunology; D002908:Chronic Disease; D016207:Cytokines / Q000276:immunology; D004198:Disease Susceptibility / Q000276:immunology; D005491:Focal Infection, Dental / Q000276:immunology; D006360:Heat-Shock Proteins / Q000276:immunology; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology; D010510:Periodontal Diseases / Q000150:complications* / Q000276:immunology; D012307:Risk Factors
D016207:Cytokines; D006360:Heat-Shock Proteins; D018836:Inflammation Mediators